The Shift to Autologous and Allogeneic: Key Market Trends in CAR T-Cell Product Development and Delivery in India
  The emergence of CAR T-cell therapy represents one of the most significant revolutions in oncology, particularly for the treatment of hematological malignancies, and its trajectory in the Indian subcontinent is a tale of immense scientific potential struggling against massive accessibility challenges. India, with its substantial burden of blood cancers, including aggressive B-cell...
0 Comments 0 Shares 72 Views 0 Reviews